Press release
United States Lyme Disease Diagnostics Market 2025: Industry Developments, Future Growth, Share & Industry Insights | T2 Biosystems, Inc., Bio-Rad Laboratories, Inc., Oxford Immunotec USA, Inc., Thermo Fisher Scientific
Lyme Disease Diagnostics Market - DataM Intelligence
DataM Intelligence has published a new research report on "Lyme Disease Diagnostics Market Size 2025". The report explores comprehensive and insightful Information about various key factors like Regional Growth, Segmentation, CAGR, Business Revenue Status of Top Key Players and Drivers. The purpose of this report is to provide a telescopic view of the current market size by value and volume, opportunities, and development status.
Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/lyme-disease-diagnostics-market?sg
Key Players: T2 Biosystems, Inc., Bio-Rad Laboratories, Inc., Oxford Immunotec USA, Inc., Thermo Fisher Scientific Inc., Quidel Corporation, Quest Diagnostics, BioMérieux India Private Limited, Diasorin S.p.A, Meridian Bioscience Inc., and Cortez Diagnostics Inc.
USA - Industry Latest News 2025:
✅ 2025-03-26 - LymeX Phase 4 launched (7 teams advanced) - U.S. LymeX Diagnostics Prize moved into Phase 4, inviting seven teams to run clinical validation and prepare regulatory submissions aimed at FDA review/clearance.
✅ 2025-07-03 - FDA clearance: new Lyme IgM / IgG immunoblots - A company announced FDA clearance for updated Lyme IgM and IgG immunoblot products intended to improve confirmatory serology.
✅ 2025-07-28 - ADLM/2025: AI-powered multiplex blood test presented / debuted - An AI-assisted multiplex assay (multiplex antigen panel + ML classifier) was presented at ADLM 2025 showing >90% sensitivity/specificity, touted as a major improvement for early detection. Several press pieces and meeting reports covered the result.
Europe - Industry Latest News 2025:
✅ 2025-(ongoing) - DiaSorin activity: LIAISON Lyme solutions / regulatory filings - DiaSorin's LIAISON® LymeDetect and related LIAISON Lyme solutions continue to be promoted in EU markets and have been under regulatory review/submission activity toward broader approvals/CLIA / automated workflows. (company materials / product pages).
✅ 2025-(throughout year) - EUROIMMUN / Mikrogen - product updates & IVDR compliance - EUROIMMUN keeps promoting its Lyme immunoassays across Europe (screening, confirmatory, CSF panels). Mikrogen also announced product updates / new assay launches and IVDR conformity work in 2025 (company press). These are incremental product-launch / compliance moves rather than single high-profile M&A.
✅ 2025-03-24 - Study flags discrepancies across widely used serological methods in Europe - A 2025 preprint/study highlighted performance differences among serologic assays, reinforcing the push for improved tests/standards in EU labs.
Growth Forecast Projected:
The Global Lyme Disease Diagnostics Market is anticipated to rise at a considerable rate during the forecast period, between 2025 and 2032. In 2024, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.
Research Process:
Both primary and secondary data sources have been used in the global Lyme Disease Diagnostics Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.
Buy Now & Get 30% OFF - (Grab 50% OFF on 2+ reports): https://www.datamintelligence.com/buy-now-page?report=lyme-disease-diagnostics-market?sg
Key Segments:
By Test Type (Serological Test, Urine Antigen Tests, Lymphocytic Transformation Test Immunofluorescent Staining, Nucleic Acid Test)
By Test Sample (Blood, Cerebrospinal Fluid, Urine)
By End-User (Hospitals, Diagnostic Centers, Ambulatory Surgical Centers, Public/Private Laboratories, Physician's Office)
By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)
Regional Analysis for Market:
⇥ North America (U.S., Canada, Mexico)
⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)
⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)
⇥ South America (Colombia, Brazil, Argentina, Rest of South America)
⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)
Benefits of the Report:
Chapter 1: Sets the stage by outlining the report's coverage, summarizing key market segments by region, product type, and application. Presents a snapshot of market sizes, growth potential across segments, and anticipated industry evolution both short and long term.
Chapter 2: Highlights pivotal market insights and uncovers the most significant emerging trends driving change within the industry.
Chapter 3: Offers an in-depth look at the competitive landscape among Lyme Disease Diagnostics producers, including revenue shares, strategic moves, and recent mergers and acquisitions.
Chapter 4: Presents comprehensive profiles of the market's key players, delving into details such as revenue, profit margins, product portfolios, and company milestones.
Chapters 5 & 6: Analyze Lyme Disease Diagnostics revenue at both regional and country levels, providing quantitative breakdowns of market sizes, growth opportunities, and development prospects worldwide.
Chapter 7: Focuses on different market segments by type, examining their individual sizes and potential, guiding readers toward high-impact, untapped market areas.
Chapter 8: Explores segmentation by application, evaluating industry growth potential in various downstream markets and pinpointing promising sectors for expansion.
Chapter 9: Provides a thorough review of the industry's supply chain mapping out both upstream and downstream activities.
Chapter 10: Concludes with a summary of the report's key findings and highlights the most critical takeaways for industry stakeholders.
Get Customization in the report as per your requirements: https://datamintelligence.com/customize/lyme-disease-diagnostics-market?sg
FAQ's
Q1: What is the current size of the Lyme Disease Diagnostics Market?
A: The Lyme Disease Diagnostics Market stood at USD 1.6 billion in 2022 and is set to experience remarkable growth, reaching USD 2.2 billion by 2030
Q2: How fast is the Lyme Disease Diagnostics Market growing?
A: The Market is on an impressive growth trajectory, expected to expand at a CAGR of 4.3% from 2024-2031.
Q3: Which regions are dominating the Lyme Disease Diagnostics Market and which are fastest-growing?
A: North America Region Holds the Largest Market Share in the Global Lyme Disease Diagnostics Market.
Have any Query We Will Provide in Detailed @ https://www.datamintelligence.com/enquiry/lyme-disease-diagnostics-market?sg
Power your decisions with real-time competitor tracking, strategic forecasts, and global investment insights all in one place.
Have a look at our Subscription Dashboard: https://www.youtube.com/watch?v=x5oEiqEqTWg
Get 2-Day Free Trial + 50% OFF DataM Subscription@ https://www.datamintelligence.com/reports-subscription?sg
Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com
About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release United States Lyme Disease Diagnostics Market 2025: Industry Developments, Future Growth, Share & Industry Insights | T2 Biosystems, Inc., Bio-Rad Laboratories, Inc., Oxford Immunotec USA, Inc., Thermo Fisher Scientific here
News-ID: 4253067 • Views: …
More Releases from DataM Intelligence 4 Market Research LLP
Breakthrough Nutritional Ingredients Poised to Capture USD 325.4 Billion by 2031 …
The Global Nutritional Ingredients Market was valued at USD 182.5 billion in 2022 and is projected to reach USD 325.4 billion by 2031, growing at a CAGR of 7.5% during the forecast period 2024-2031. This robust growth is driven by a profound and global consumer shift towards health and wellness, the accelerating adoption of vegan and plant-based lifestyles, an aging global population seeking preventative nutrition, and the rapid expansion of…
United States Aluminum Powder Market to Hit $3.71 Billion by 2032 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" Global Aluminum Powder Market Size reached US$ 7.32 billion in 2024 and is expected to reach US$ 12.39 billion by 2032, growing with a CAGR of 6.80% during the forecast period 2025-2032." Lightweight materials demand and additive manufacturing growth are boosting aluminum powder usage.
Download your exclusive sample report today: (corporate email gets priority access):
https://www.datamintelligence.com/download-sample/aluminum-powder-market?Prasad
United States: Recent Industry…
North America Non-Steroidal Anti-Inflammatory Drugs Market to Reach $17.27 Billi …
Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" The North America non-steroidal anti-inflammatory drugs market size reached US$ 8.34 billion in 2024 and is expected to reach US$ 17.27 billion by 2033, growing at a CAGR of 7.6% during the forecast period 2025-2033." Chronic pain prevalence and OTC self-care trends continue to strengthen the NSAIDs market.
Download your exclusive sample report today: (corporate email gets priority access):…
United States Gene Therapy Market to Hit $6510.45 Million by 2033 | Leading comp …
Leander, Texas and Tokyo, Japan - Dec.10.2025
As per DataM intelligence research report" The US Gene Therapy Market Size reached US$ 2,812.92 million in 2024 and is expected to reach US$ 21,701.51 million by 2033, growing at a CAGR of 23.5 % during the forecast period 2025-2033." Advances in viral vectors and precision medicine are driving rapid progress in the US gene therapy market.
Download your exclusive sample report today: (corporate…
More Releases for Lyme
Lyme Disease Diagnostics Market Projected to Show Strong Growth
Advance Market Analytics published a new research publication on "Lyme Disease Diagnostics Market Insights, to 2033" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Lyme Disease Diagnostics market was mainly driven by the increasing R&D spending across the world.
Get Free Exclusive PDF Sample…
Lyme Disease - Drug Pipeline Landscape, 2022
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash.
Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems.
To know more about Lyme Disease - Drug Pipeline ,…
Lyme Disease - Drug Pipeline Landscape, 2022 | Global Insight Services
Lyme disease is a tick-borne infection caused by four main species of bacteria Borrelia burgdorferi, Borrelia mayonii, Borrelia afzelii and Borrelia garinii. The disease is characterized by skin rash. Early signs and symptoms of Lyme disease include rash and other symptoms like fever, chills, fatigue, body aches, and swollen lymph nodes. Later symptoms include erythema migrans, joint pain and other neurological problems. Diagnosis of Lyme disease involves lab tests to…
Lyme Disease Vaccines - Are They Effective?| Valneva, GlaxoSmithKline Plc.
There is currently no Lyme disease vaccine available. LYMERix®, the only vaccine previously marketed in the United States, was withdrawn from the market in 2002 due to a lack of consumer demand. The vaccine's effectiveness deteriorates over time.
Lyme Disease Vaccines Market research is an intelligence report with meticulous efforts undertaken to study the right and valuable information. The data which has been looked upon is done considering both, the existing…
Lyme Disease Therapeutics Market Size Statistics, Facts and Figures
Global Lyme Disease Therapeutics Market: Overview
Lyme disease is a contagious disease caused by a bacterium species called Borrelia burgdorferi. It is a tick-borne disease caused by transmission of bacteria to humans through the bite of infected ticks. Common indications of Lyme disease include flu-like symptoms, depression, fatigue, and expanding, circular, reddish skin rashes.
View Report : https://www.transparencymarketresearch.com/lyme-disease-therapeutics-market.html
If left untreated, these symptoms may worsen and can lead to partial or complete…
Lyme Disease Diagnostic Testing Market
The report presents a detailed analysis of the Lyme disease diagnostics market in the US, Europe (France, Germany, Italy, Spain, UK) and Japan. Current scientific views on the Lyme disease definition, epidemiology and etiology are reviewed. The report provides the 5-year test volume and sales forecasts by country for the following market segments:
- Hospitals
- Commercial/Private Labs
…
